Adherium $35m ASX IPO to expand sales of digital health technology to improve medication adherence
– Digital health company’s technology proven to improve adherence and patient health in chronic respiratory disease – $25.85m in signed commitments, AstraZeneca US$3m cornerstone investment; led by Bell Potter Securities – First-in-class 10 year Supply and Development Agreement with AstraZeneca – Technology has been used in 40 projects, across 29 countries, with 32 publications referencing Smartinhaler 5 August 2015 […]